7-2526206-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001040167.2(LFNG):c.822-38C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00156 in 1,609,138 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0020 ( 8 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 47 hom. )
Consequence
LFNG
NM_001040167.2 intron
NM_001040167.2 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.78
Genes affected
LFNG (HGNC:6560): (LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase) This gene is a member of the glycosyltransferase 31 gene family. Members of this gene family, which also includes the MFNG (GeneID: 4242) and RFNG (GeneID: 5986) genes, encode evolutionarily conserved glycosyltransferases that act in the Notch signaling pathway to define boundaries during embryonic development. While their genomic structure is distinct from other glycosyltransferases, these proteins have a fucose-specific beta-1,3-N-acetylglucosaminyltransferase activity that leads to elongation of O-linked fucose residues on Notch, which alters Notch signaling. The protein encoded by this gene is predicted to be a single-pass type II Golgi membrane protein but it may also be secreted and proteolytically processed like the related proteins in mouse and Drosophila (PMID: 9187150). Mutations in this gene have been associated with autosomal recessive spondylocostal dysostosis 3. [provided by RefSeq, May 2018]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 7-2526206-C-T is Benign according to our data. Variant chr7-2526206-C-T is described in ClinVar as [Benign]. Clinvar id is 257270.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00203 (309/152326) while in subpopulation EAS AF= 0.0487 (252/5178). AF 95% confidence interval is 0.0437. There are 8 homozygotes in gnomad4. There are 161 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LFNG | NM_001040167.2 | c.822-38C>T | intron_variant | ENST00000222725.10 | NP_001035257.1 | |||
LFNG | NM_001040168.2 | c.822-38C>T | intron_variant | NP_001035258.1 | ||||
LFNG | NM_001166355.2 | c.609-38C>T | intron_variant | NP_001159827.1 | ||||
LFNG | NM_002304.3 | c.435-38C>T | intron_variant | NP_002295.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LFNG | ENST00000222725.10 | c.822-38C>T | intron_variant | 5 | NM_001040167.2 | ENSP00000222725.5 |
Frequencies
GnomAD3 genomes AF: 0.00205 AC: 312AN: 152208Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
312
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00462 AC: 1140AN: 246806Hom.: 26 AF XY: 0.00418 AC XY: 562AN XY: 134298
GnomAD3 exomes
AF:
AC:
1140
AN:
246806
Hom.:
AF XY:
AC XY:
562
AN XY:
134298
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00151 AC: 2194AN: 1456812Hom.: 47 Cov.: 32 AF XY: 0.00142 AC XY: 1033AN XY: 724946
GnomAD4 exome
AF:
AC:
2194
AN:
1456812
Hom.:
Cov.:
32
AF XY:
AC XY:
1033
AN XY:
724946
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00203 AC: 309AN: 152326Hom.: 8 Cov.: 32 AF XY: 0.00216 AC XY: 161AN XY: 74478
GnomAD4 genome
AF:
AC:
309
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
161
AN XY:
74478
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
80
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at